Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
JARID2 antisense RNA 1 (JARID2-AS1) is a long non-coding RNA (lncRNA) transcribed from the first intron of the JARID2 gene in the antisense direction[2]. It does not code for a protein and is primarily localized in the cell nucleus, where its expression is tightly anti-correlated with that of JARID2 mRNA[2]. It has been shown to interact with the Polycomb repressive complex 2 (PRC2), a key chromatin-modifying complex involved in developmental gene regulation. JARID2-AS1 is thought to participate in a regulatory loop by recruiting PRC2 to the JARID2 locus, thereby regulating JARID2 expression itself and contributing to the control of developmental and differentiation processes[2]. Its mechanism suggests an autoregulation of the JARID2 gene via epigenetic modulation, but JARID2-AS1 itself is not considered a classical therapeutic target such as a receptor, enzyme, or ion channel[2]. No drugs are currently known to target JARID2-AS1 directly, nor are specific safety concerns, biomarkers, or established roles as a therapeutic target described in the literature[2]. Its primary recognized function is the epigenetic modulation of gene expression through interaction with chromatin regulators in developmental contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on JARID2 antisense RNA 1 (JARID2-AS1).